HomeORGANIZATION
ORGANIZATION

Expand Exemption Criteria in New Off-Patent Price Cut Rule: Japan Pharma Lobby
(Jun.19.2018)

The government should revisit the scope of products subject to a new price cut scheme for off-patent brand-name products as its application currently includes drugs with refractory disease indications and other medicines that should be excluded from its coverage, Japan’s largest pharma lobby said on June 15 ...
(LOG IN FOR FULL STORY)

News Calendar